Nakayama T, Niikura N, Yamanaka T, Yamamoto M, et al. Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM). Breast Cancer 2024 Sep 20. doi: 10.1007/s12282-024-01632.
PMID: 39302559